Related by context. All words. (Click for frequent words.) 71 AST ALT 71 glomerular filtration 70 relapsed MM 70 hepatic cirrhosis 70 β blockers 70 hepatic enzymes 70 haematologic 69 liver histology 69 EGFRIs 69 colorectal adenoma 69 aspartate aminotransferase 68 posttreatment 68 Hematologic 68 leukocyte counts 68 serum BDNF 68 TMP SMX 68 Hypotension 68 paricalcitol 68 hepatorenal syndrome 68 eculizumab therapy 68 pharmacodynamic parameters 68 hypocalcaemia 68 pentoxifylline 67 liver transaminases 67 serum cortisol 67 PASI scores 67 nitrofurantoin 67 epoetin alpha 67 oral anticoagulant therapy 67 eosinophilia 67 metabolite concentrations 67 Hepatotoxicity 67 aspartate aminotransferase AST 67 hematological parameters 67 CPAP adherence 67 hepatic enzyme 67 clomipramine 67 serum urate levels 67 Retreatment 67 SGPT 67 serum phosphate 67 Creatinine 67 QTc prolongation 66 neuroleptic 66 procalcitonin 66 cranial irradiation 66 serum IgG 66 griseofulvin 66 hypomagnesemia 66 steroid dexamethasone 66 plasma cortisol 66 neutropaenia 66 symptomatic VTE 66 Histological 66 hepatic function 66 aminotransferases 66 perioperatively 66 EXJADE 66 intestinal permeability 66 nephrotoxicity 66 bullous 66 sitaxsentan 66 urinary N telopeptide 66 pyridostigmine 66 ALT flares 66 concomitant medications 66 leucopenia 66 Febrile neutropenia 66 transaminase levels 66 electrophysiologic 66 Natalizumab 66 APTIVUS r 66 acamprosate calcium 66 Postoperative complications 66 extrapyramidal symptoms 66 Viral load 66 postprocedure 66 intravenous bisphosphonates 66 thromboembolic disease 66 serum phosphate levels 66 conventional DMARDs 66 airway hyperresponsiveness 66 hypercalciuria 66 aminotransferase 65 antitumor efficacy 65 urinary oxalate 65 transaminase elevations 65 serum lactate 65 postoperative AF 65 HER2 expression 65 angiographically 65 trastuzumab Herceptin ® 65 erythropoietic 65 EDARBI 65 hypophosphatemia 65 glycosylated hemoglobin HbA1c 65 serum urate 65 paraprotein 65 bronchial hyperresponsiveness 65 serum lipid 65 alanine aminotransferase 65 baseline LDH 65 serum homocysteine 65 tylosin 65 serum aminotransferase levels 65 alanine aminotransferase ALT 65 mycophenolate mofetil MMF 65 sacral neuromodulation 65 intestinal motility 65 esophageal reflux 65 Serum creatinine 65 urolithiasis 65 vascular reactivity 65 invasive aspergillosis 65 plasma pharmacokinetics 65 serum creatinine levels 65 CTEPH 65 bone scintigraphy 65 intravascular hemolysis 65 H. pylori eradication 65 salivary flow 65 somatostatin analogs 65 acromegalic patients 65 intact parathyroid hormone 65 aldosterone antagonist 65 p = #.# [003] 65 elevated ALT 65 HbA 1c levels 65 serum sodium levels 65 haemolysis 65 anemia thrombocytopenia 65 tigecycline 65 riociguat 65 sitosterol 65 amisulpride 65 triglyceride concentrations 65 serum calcium levels 65 endometrial hyperplasia 65 Symptom severity 65 Subgroup analyzes 65 hematological toxicity 65 plasma creatinine 65 chronic urticaria 65 bronchoalveolar lavage 65 systemic corticosteroid 65 intracerebral haemorrhage 65 induced sputum 65 histological subtype 65 divalproex sodium 65 STRIDE PD 65 gadobutrol 65 dose proportionality 65 ß blockers 64 hepatic fibrosis 64 thiopurine 64 mucosal inflammation 64 urothelial cancer 64 neuropsychiatric symptoms 64 eplerenone 64 candidemia 64 FDG PET imaging 64 efalizumab 64 Brief Psychiatric 64 hemodynamic variables 64 hsCRP levels 64 exploratory endpoints 64 d dimer 64 KAPIDEX 64 GH deficiency 64 MYCAMINE 64 ULORIC 64 sweat chloride 64 Teriflunomide 64 hepatic toxicity 64 c reactive protein 64 abacavir Ziagen 64 CANCIDAS 64 fosamprenavir 64 clinicopathological 64 serum HBV DNA 64 follicular lymphoma FL 64 cytologic 64 pretransplant 64 serum parathyroid hormone 64 pretreatment serum 64 CYP#D# inhibitor 64 venous thromboembolic disease 64 platelet reactivity 64 diabetic polyneuropathy 64 bisoprolol 64 torsade de pointes 64 acetylcysteine 64 myopathy rhabdomyolysis 64 liver metastasis 64 hepatic arterial 64 unresectable HCC 64 hyperalgesia 64 corticosteroid therapy 64 dual endothelin receptor antagonist 64 metabolic parameters 64 rFVIIa 64 Primary endpoints 64 differential gene expression 64 femoral neck fracture 64 Histologic 64 transaminases 64 postoperative complication 64 allogeneic HSCT 64 Pharmacokinetic parameters 64 tissue oxygenation 64 CsA 64 glycated hemoglobin levels 64 nimodipine 64 quetiapine Seroquel 64 liposomal amphotericin B 64 Platinol ® 64 severe hypersensitivity reactions 64 LVNC 64 Postoperative 64 ATACAND 64 hepatic encephalopathy HE 64 intravenous diuretics 64 histologic subtype 64 histopathologic examination 64 renal biopsy 64 primary aldosteronism 64 interstitial fibrosis 64 histologic findings 64 severe exacerbations 64 Toxicities 64 bronchoalveolar 64 parasitological 64 postintervention 64 salmeterol fluticasone 64 Cardiotoxicity 64 percutaneous vertebroplasty 64 urinary calcium 64 antihypertensive therapy 64 thyrotoxicosis 64 NSAID induced 64 fluvastatin 64 octreotide LAR 64 antimicrobial susceptibility 64 macroalbuminuria 64 hyperammonemia 64 genotypic resistance 64 calculated creatinine clearance 64 #F FDG PET 64 radiographic findings 64 hyperprolactinemia 64 amoxicillin clavulanate 64 thalidomide Thalomid 64 BARACLUDE ® 64 HER2 overexpression 64 coagulation parameters 64 solifenacin 64 tolterodine ER 64 mitomycin C 64 vasogenic edema 64 viral titers 64 pulmonary toxicity 64 demonstrated clinically meaningful 63 tipranavir r 63 TPMT 63 antithymocyte globulin 63 androgen ablation 63 BEXXAR Therapeutic Regimen 63 recurrent venous thromboembolism 63 atherogenic dyslipidemia 63 Subgroup analysis 63 Psoriasis Area 63 troponins 63 antiarrhythmic drug 63 ximelagatran 63 gemifloxacin 63 SCr 63 chemoradiation therapy 63 lichen planus 63 gastroduodenal 63 eNO 63 ALT AST 63 aspirin clopidogrel 63 primary hyperparathyroidism 63 viral kinetics 63 hemodilution 63 Insulin sensitivity 63 serum phosphorous 63 serum potassium 63 betamethasone 63 prolonged QT interval 63 CIMZIA R 63 adrenal function 63 antioxidant supplementation 63 bacteriuria 63 Crohn Disease Activity 63 serum lipids 63 AGILECT R 63 immunostaining 63 hypericin 63 hypoperfusion 63 pulmonary exacerbations 63 invasive candidiasis 63 antiresorptive 63 Alequel 63 antiangiogenic therapy 63 prospectively stratified 63 strontium ranelate 63 tegaserod 63 serum lipid levels 63 antiviral efficacy 63 Postoperatively 63 diabetic kidney 63 haemodynamic 63 homocysteine concentrations 63 PRADAXA #mg 63 serum bicarbonate 63 MULTAQ 63 cardiac conduction 63 carcinomatosis 63 SGRQ 63 zoledronate 63 SUVmax 63 specific IgE 63 primidone 63 gallium nitrate 63 circulating endothelial cells 63 anterior uveitis 63 vasodilatation 63 ritonavir boosted 63 folinic acid 63 inflammatory biomarkers 63 metastatic malignant 63 neurodevelopmental outcome 63 fatigue diarrhea nausea 63 RISPERDAL ® 63 MS relapses 63 azacytidine 63 Sjögren syndrome 63 affective psychosis 63 myocardial viability 63 plasminogen activators 63 HSCT 63 artery stenosis 63 left ventricular diastolic 63 INVEGA ® 63 KETEK 63 hepatic lesions 63 poststroke depression 63 HpSA 63 lactate dehydrogenase 63 argatroban 63 antirheumatic 63 Legg Calvé Perthes disease 63 analgesic medications 63 BENICAR HCT 63 enterococcal 63 corneal neovascularization 63 parasitemia 63 morphometric vertebral fractures 63 pulmonary exacerbation 63 IV bisphosphonates 63 F FDG PET 63 N telopeptide 63 topical calcineurin inhibitors 63 extramedullary 63 SSc 63 metaplasia 63 renal toxicity 63 Bisphosphonate 63 lactate dehydrogenase LDH 63 hypofractionated radiation 63 colorectal liver metastases 63 hyperinsulinemic euglycemic clamp 63 elevated creatinine 63 mesilate 63 retinal thickness 63 Plaquenil 63 GnRH agonists 63 Known hypersensitivity 63 mitochondrial toxicity 63 Adverse effects 63 CP CPPS 63 Severity Index PASI 63 thrombotic complications 63 pyrazinamide 63 levodopa carbidopa 63 hepatic liver 63 albumin excretion 63 NIASPAN 63 renal cysts 63 gastrointestinal toxicity 63 posttransplant 63 recurrent glioblastoma multiforme 63 isoprostane 63 hyperhomocysteinemia 63 #mg/day [001] 63 rituximab Rituxan 63 flecainide 63 infliximab Remicade 63 antigen PSA levels 63 inducible nitric oxide synthase 63 pharmacodynamic PD 63 apneic episodes 63 HBeAg seroconversion 63 erythema nodosum 63 postoperative mortality 63 gastrointestinal perforation 63 hematologic toxicity 62 desvenlafaxine succinate 62 serum IGF 62 LOVENOX R 62 neovascular 62 hepatic insufficiency 62 intra abdominal abscess 62 choroidal vasculopathy 62 cardiac repolarization 62 resected pancreatic cancer 62 atrioventricular block 62 INVEGA ™ 62 interferon ribavirin 62 receiving XGEVA 62 Teriparatide 62 metastatic lymph nodes 62 multivariable analyzes 62 DAS# scores 62 BCR ABL mutations 62 clevidipine 62 bezafibrate 62 VaD 62 arterial oxygen saturation 62 preterm newborns 62 hepatotoxic 62 incidence ≥ 62 deep venous thromboses 62 Non inferiority 62 ruboxistaurin 62 Microalbuminuria 62 pressure natriuresis 62 eosinophilic pneumonia 62 parkinsonian symptoms 62 serologically active patients 62 timepoints 62 aminotransferase levels 62 radioiodine therapy 62 intensive statin therapy 62 coadministration 62 albumin excretion rate 62 premenopause 62 fibrin deposition 62 Cystatin C 62 antithrombotic therapy 62 ergocalciferol 62 serum PSA 62 perfusion MRI 62 CellCept mycophenolate mofetil 62 glycaemia 62 neutrophil counts 62 DAS# CRP 62 thrombocytopenic 62 intima media thickness 62 danazol 62 receiving VELCADE 62 Pharmacodynamic 62 HAQ DI 62 endothelial activation 62 glycosylated hemoglobin levels 62 creatine kinase 62 histopathological 62 concurrent chemoradiation 62 gonococcal 62 MYLOTARG 62 headache abdominal pain 62 candesartan cilexetil 62 PSADT 62 myocardial reperfusion 62 chronic thromboembolic pulmonary 62 neurodevelopmental outcomes 62 lenalidomide dexamethasone 62 urothelial carcinoma 62 C telopeptide 62 serum ALT 62 NPH insulin 62 pulmonary dysfunction 62 PCWP 62 Gram stain 62 Captopril 62 cellularity 62 intraocular pressure IOP 62 macrolide antibiotic 62 metabolic acidosis 62 CIMZIA ™ 62 hypocalcemia 62 antimetabolites 62 anagrelide 62 Pemetrexed 62 FluCAM arm 62 esophagogastric 62 hypercholesterolaemia 62 Follicular Lymphoma 62 intravenous vancomycin 62 demyelinating 62 hyperphenylalaninemia HPA due 62 vitreous floaters 62 cholestasis 62 ADCS ADL 62 nasopharyngitis headache 62 enalapril 62 leukotriene receptor antagonist 62 antiandrogens 62 imatinib therapy 62 pulmonary hypertension PH 62 TNF antagonist 62 mycophenolate mofetil 62 lumbar spine bone 62 iPTH 62 INFERGEN 62 lymphocyte counts 62 gastric adenocarcinoma 62 Afatinib 62 SGOT 62 scintigraphic 62 systemic hypotension 62 tolvaptan 62 oncologic outcomes 62 Pharmacodynamics 62 intravenous dosing 62 Tumor Response 62 extracellular dopamine 62 histopathologic diagnosis 62 intravitreal injections 62 haematological 62 Candida infection 62 MGd 62 ara C 62 atypical neuroleptics 62 vWF 62 Ceplene/IL-2 62 calculi 62 hypothalamic pituitary 62 plasma renin activity 62 cerebral vasospasm 62 Index CDAI 62 certolizumab 62 Helicobacter pylori eradication 62 postoperative morbidity 62 nicardipine 62 platelet dysfunction 62 antitumor effect 62 pioglitazone HCl 62 immunoreactivity 62 Carbamazepine 62 probiotic supplementation 62 recurrent UTI 62 antibody titer 62 calcineurin inhibitors 62 Heavy menstrual bleeding 62 unresectable tumors 62 nasal polyposis 62 CYP#A# substrate 62 Humate P 62 neurologic deficits 62 androgen suppression 62 triacylglycerol concentrations 62 ibandronate 62 urinary protein 62 Ejection Fraction 62 serum antibody 62 Atomoxetine 62 hyperparathyroidism 62 immunomodulatory agents 62 atherosclerotic renal artery stenosis 62 MADRS score 62 adrenocorticotropic hormone ACTH 62 salivary cortisol 62 Lipoic acid 62 KRAS mutant tumors 62 myocardial infarct size 62 therapeutic regimens 62 vulvovaginal candidiasis 62 sargramostim 62 oral anticoagulation 62 conjugated estrogen 62 ispinesib administered 62 ALA PDT 62 TEAEs 62 cediranib 62 HIV HCV coinfected 62 bone marrow suppression 62 serotonin synthesis 62 oxcarbazepine 62 neurocognitive function 62 BYSTOLIC 62 clinically meaningful improvements 62 carotid artery stenting CAS 62 SSRI SNRI 62 G6PD deficiency 62 adrenal suppression 62 tumor necrosis 62 mycophenolate 62 thrombotic thrombocytopenic purpura TTP 62 immunosuppressant therapy 62 Double Blind Randomized 62 guanfacine extended release 62 mild renal insufficiency 62 chemosensitivity 62 serum sodium 62 GH secretion 62 nicotinic acid 62 endometrial carcinoma 62 constipation predominant IBS 62 beta blocker therapy 62 tryptase 62 NIHSS 62 leukoencephalopathy 62 basiliximab 62 ACTOS ® 62 demonstrated antitumor activity 62 mutated KRAS 62 urinary excretion 62 radiographic outcomes 62 ventricular repolarization 62 diarrhea flatulence 62 ANCA associated 62 empiric treatment 62 pancreatectomy 62 urine albumin 62 eosinophil count 62 antiplatelet medication 62 microsatellite instability 62 GnRH agonist 62 IFN alfa 62 reticulocytes 62 tacrolimus ointment 62 nattokinase 61 adenoma recurrence 61 canakinumab 61 pegylated interferon alfa 61 prednisone prednisolone 61 IOP lowering 61 posaconazole 61 univariate analyzes 61 Proteinuria 61 acute respiratory tract infections 61 urodynamic 61 serum PTH 61 Nebulized 61 voriconazole 61 definite stent thrombosis 61 neutropenic patients 61 hematopoietic cancers 61 Topical corticosteroids 61 SPRYCEL ® 61 CIN3 61 symptomatic paroxysmal AF 61 cTnI 61 ziconotide 61 esophageal carcinoma 61 Decitabine 61 Peripheral edema 61 azelaic acid 61 Platelet counts 61 transcranial Doppler ultrasound 61 tumor perfusion 61 creatinine levels 61 lipid parameters 61 FOLFIRI alone 61 plasma triglycerides 61 isoproterenol 61 meta regression 61 immunohistochemical 61 drug eluting stent implantation 61 elevated IOP 61 Dasatinib 61 Hypercholesterolemia 61 somatostatin analogues 61 intermittent dosing 61 calcineurin inhibitor 61 NATRECOR ® 61 interleukin IL -# 61 ACTEMRA TM 61 antiplatelet therapies 61 symptomatic intracranial 61 PRADAXA 61 weekly subcutaneous injections 61 flutamide 61 abnormal cytology 61 esophageal candidiasis 61 clinicopathological features 61 IL 1ß 61 external beam radiotherapy 61 Tumor shrinkage 61 endothelium dependent 61 ethambutol 61 pancytopenia 61 antimuscarinic 61 monogenic 61 transaminase 61 intracranial hemorrhage ICH 61 ER CHOP 61 adenomatous 61 moderate renal impairment 61 PSA nadir 61 IFN beta 61 Estradiol 61 pathologic fractures 61 psychosocial variables 61 KRAS status 61 Electrophysiological 61 elevated LDH 61 thyroid stimulating hormone 61 coinfected patients 61 nausea constipation 61 echocardiographic parameters 61 imipenem 61 microvessel density 61 epoetin beta 61 ALT elevations 61 GI bleeds 61 parenteral antibiotics 61 fosbretabulin 61 biologic DMARD 61 deferiprone 61 mg BID dose 61 ERalpha 61 microcirculatory 61 NMIBC 61 atheroma volume 61 hypertonic saline 61 TNF α 61 vitamin B# folic acid 61 symptomatic intracranial hemorrhage 61 elevated transaminases 61 QTc intervals 61 NAbs 61 overactive bladder symptoms 61 postoperative atrial fibrillation 61 abacavir lamivudine 61 fibrinolysis 61 intracerebral 61 prolactin elevation 61 serum retinol 61 GI motility 61 Ribavirin causes 61 Renal dysfunction 61 hyperoxaluria 61 levodopa therapy 61 #mg/day [002] 61 HepG2 cells 61 immune modulating 61 antiemetics 61 Chronic Renal Failure 61 CYP #D# 61 oxycodone CR 61 antibiotic prophylaxis 61 symptomatic hypotension 61 interferon γ 61 mitoxantrone plus 61 antimicrobial prophylaxis 61 vaso occlusive crisis 61 endoscopic ultrasonography 61 infective endocarditis 61 oesophagitis 61 Kepivance 61 FDA defined valvulopathy 61 MAGE A3 ASCI 61 pleural fluid 61 Myelosuppression 61 PsA 61 FDG uptake 61 metastatic neuroendocrine tumors 61 neutrophil count 61 heparin induced thrombocytopenia 61 cardiac allograft vasculopathy 61 neurologic outcomes 61 mg kg dose 61 immunosuppressive therapies 61 QD dosing 61 spirometric 61 Meta analyzes 61 Myocardial 61 complement inhibitor eculizumab 61 Efficacy endpoints 61 timepoint 61 Exacerbations 61 corticosteroid dose 61 SIADH 61 reactogenicity 61 potent antiretroviral therapy 61 intravesical therapy 61 adriamycin 61 repolarization 61 nondiabetic patients 61 granulomatous 61 HAART regimen 61 paroxysmal nocturnal hemoglobinuria 61 Fulvestrant 61 XEPLION R 61 FUSILEV enhances 61 anemia hemoglobin 61 alfuzosin 61 Septic Shock 61 postoperative hemorrhage 61 zonisamide SR 61 bronchoalveolar lavage fluid 61 fatty infiltration 61 radiographic progression 61 coagulopathy 61 radiosensitivity 61 fluoroquinolone resistance 61 Certolizumab pegol 61 immunotoxicity 61 Relapsing Remitting Multiple Sclerosis 61 symptom severity 61 prostaglandin analogues 61 Hydroxyurea 61 Renal impairment 61 penicillin allergy 61 Pegylated Interferon 61 Bioavailability 61 NIH CPSI 61 ursodeoxycholic acid 61 dalteparin 61 Nonspecific 61 Respiratory Symptoms 61 STELARA ™ 61 HPA axis suppression 61 neuroleptics 61 induce orthostatic hypotension 61 fasting plasma 61 acute mania 61 DOXIL 61 Thalomid ® 61 thyroglobulin 61 imatinib resistance 61 prucalopride 61 Elevated serum 61 viraemia 61 reflux esophagitis 61 secondary hyperparathyroidism 61 atypical ductal hyperplasia 61 intraventricular 61 latent tuberculosis TB 61 Dacogen decitabine 61 rFSH 61 CIMZIA TM 61 Echocardiographic 61 cytopenias 61 dorzolamide 61 ocular allergy 61 ADAGIO study 61 seminomas 61 Cimzia TM 61 gross hematuria 61 olmesartan 61 ARCOXIA 61 leukocytosis 61 ventricular tachyarrhythmia 61 serum calcium 61 myeloperoxidase 61 selective modulator 61 imiquimod cream 61 cystoscopic 61 flow mediated dilation 61 FXIII 61 Replikin Count 61 thyrotropin 61 Parkinsonian symptoms 61 detectable HCV RNA 61 docetaxel chemotherapy 61 dosimetric 61 pituitary hormone 61 neurocognitive outcomes 61 Akathisia 61 alkylating agent 61 Secondary efficacy endpoints 61 interobserver 61 vasoactive 61 cardiac revascularization 61 thrombocytopenic patients 61 moderately emetogenic 61 neurosensory 61 perioperative morbidity 61 stone formers 61 natriuretic peptides 61 Tasigna prolongs 61 statins cholesterol lowering 61 chest radiographs 61 L lysine 61 gastrointestinal stromal tumors GIST 61 anticholinergic agents 61 cerebral oxygenation 61 nephrolithiasis 61 Erythropoietic therapies may 61 undergoing peritoneal dialysis 61 N acetylcysteine 61 idarubicin 61 poststroke 61 thromboembolic 61 neutropenic 61 radicular 61 Plasma concentrations 61 postoperative infections 61 Adenomas 61 rhTSH 61 See CLINICAL PHARMACOLOGY 61 transgene expression 61 antibiotic rifaximin 61 diabetic gastroparesis 61 atazanavir ritonavir 61 hypotensive 61 adrenal insufficiency 61 cystoid macular edema 61 im peramivir 61 neuritic 61 NYHA functional class 61 tamponade 61 digoxin toxicity 61 Intravitreal 61 prospective multicenter study 61 bisacodyl 61 Doxil ® 61 prostate abnormalities 61 rCBF 61 bacteremic 61 bacterial prostatitis 61 urate levels 61 Kinoid 61 FASLODEX 61 mycosis fungoides 61 retrograde ejaculation 61 Visual acuity 61 vesicoureteral reflux 61 racemic albuterol 61 bone metabolism 61 transfusion syndrome 61 sJIA 61 anticoagulant medication 61 oropharyngeal 61 nephrogenic 61 comorbid depression 61 haematuria 61 sputum induction 61 serum triglycerides 61 periprocedural 61 INVEGA ® SUSTENNA TM 61 megestrol acetate 61 D Dimer 61 airway responsiveness 61 hA# 61 Clinically significant 61 cytopenia 61 APTIVUS 61 mineral density BMD 61 hypercalcaemia 61 ADPKD 61 thyroid deficiency 60 CSF biomarkers 60 LAB CGRP 60 fulminant hepatic failure 60 Multivariate logistic regression 60 sulfasalazine 60 FOLPI 60 overt nephropathy 60 corrected QT interval 60 LV dysfunction 60 Endothelial dysfunction 60 Adverse Event 60 piroxicam 60 pharmacokinetic interactions 60 coronary stenosis 60 EDSS scores 60 plasma renin 60 hepatic metastases 60 Subarachnoid hemorrhage 60 PAOD 60 lesional 60 AZT zidovudine Retrovir 60 murine model 60 tranylcypromine 60 reflux symptoms 60 HBeAg 60 fibrate drugs 60 symptomatic hyponatremia 60 thromboembolic complications 60 PANSS scores 60 intratympanic 60 Estrogen Receptor 60 lipid lowering agents 60 chronic LBP 60 plasma lipid 60 abdominal adiposity 60 4mg/kg 60 Aprotinin 60 hemostatic efficacy 60 glomerular filtration rate 60 lung resection 60 Patients Receiving 60 Calcium intake 60 tHcy